Evidence map›Paper›PMID 35663132›Full record

ArticleSkin health and disease2021

Prevalence, determinants and perception of use of skin lightening products among female medical undergraduates in Nigeria.

O G Egbi, B Kasia

Open access · goldAbstract read
In one paragraph

Article in Skin health and disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Psychodermatology special edition.Skin health and disease · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

O G EgbiDepartment of Internal Medicine Niger Delta University Amassoma Bayelsa State Nigeria.ORCID https://orcid.org/0000-0001-9417-3452
B KasiaDepartment of Chemical Pathology, Niger Delta University Amassoma Bayelsa State Nigeria.
Niger Delta University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Skin Lightening Products (SLP) are common in Africa especially in Nigeria. Adverse effects from these products present a public health concern. Data on the use of these products among medical students is scanty. Objectives: The aim of the study was to determine the prevalence, determinants and perception of use of SLP among female undergraduate medical students in Nigeria. Methods: A cross-sectional descriptive study was conducted among female medical students selected by convenient sampling. An on-line survey was done with google forms using a semi-structured self-administered questionnaire containing participants' biodata, history, pattern and perception of use of SLP. Data was analyzed using IBM SPSS Statistics 20.0. Results: A total of 110 respondents completed the study with over half (62; 56.4%) of them ranging between 20 and 24 years of age. The prevalence of SLP use was 45/110(40.9%) with facial cleansers being the commonest product used [23/45(51.1%)]. Over 80% of participants knew SLP could cause adverse effects with 'skin irritation' being the most identified [71/110(64.5%)]. Although most (80%) respondents did not think that light skin was superior to dark skin, 'removal of discoloration/dark spots' (40%) and 'cosmetic reasons' (37.8%) were the commonest reasons for use. Determinants of use of SLP were light skin color (OR 3.8, 1.572-9.318), history of use among relatives (OR 3.3, 1.384-7.793) and awareness of adverse effects (OR 3.3, 1.129-9.740). Conclusion: The prevalence of use of SLP was quite high among the respondents and was predicted by 'skin color', 'use among relatives' and 'awareness of adverse effects'. Education of the general public on their adverse effects is paramount to avoid harmful use.

Indexed as

acnecancercosmeticsdiabetes

Identifiers

PMID35663132
PMCPMC9060047
OpenAlexW3164562308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.